Opendata, web and dolomites

WEAR SIGNED

Behaviour Phenotyping using Inertial Sensors

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

Project "WEAR" data sheet

The following table provides information about the project.

Coordinator
FUNDACAO D. ANNA SOMMER CHAMPALIMAUD E DR. CARLOS MONTEZ CHAMPALIMAUD 

Organization address
address: AVENIDA BRASILIA, CENTRO DE INVESTIGACAO DA FUNDACAO CHAMPALIMAUD
city: LISBOA
postcode: 1400-038
website: http://fchampalimaud.org/

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Portugal [PT]
 Total cost 149˙820 €
 EC max contribution 149˙820 € (100%)
 Programme 1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
 Code Call ERC-2018-PoC
 Funding Scheme ERC-POC
 Starting year 2019
 Duration (year-month-day) from 2019-01-01   to  2020-06-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    FUNDACAO D. ANNA SOMMER CHAMPALIMAUD E DR. CARLOS MONTEZ CHAMPALIMAUD PT (LISBOA) coordinator 149˙820.00

Map

 Project objective

Behavior is ultimately the observable output of the nervous system. Thus, to properly diagnose and monitor nervous system disorders it is crucial that we assess behavior comprehensively. However, every day clinical practice still relies mostly on subjective methods to evaluate behavior. The ability to adequately analyse behaviour is also critical during drug development, from the preclinical (animal models) to the clinical stages. Results from our ERC-funded work revealed that the combination of inertial sensor data with an unsupervised algorithm provides an optimal method for an easy to implement unbiased behavior classification that adequately captured the outcome of neural circuit’s computations. In this PoC we proposed to develop this technology into a product that provides a continuous, quantitative and comprehensive behavior assessment that is also versatile, covering the diverse spectrum from the pre-clinical to the clinical context. In this POC we will 1) refinement and validate of inertial sensors in animal models, 2) enable their integration into a Body Area Network, 3) Evolve our unsupervised algorithm into a stand-alone software that is versatile and easy to use. In addition to these technical aims, we propose to explore commercial opportunities and societal benefits, in particular in the medical and drug development sector. We will conduct market analysis and develop a business case for this product, while expanding industry contacts for production and commercialization. Our proposal will lead to a ground-breaking technical solution for quantitative, automated behavioral assessment in animal models of disease and humans that will have an important societal impact through innovation in diagnosis, disease monitoring, and drug development.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "WEAR" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "WEAR" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.1.)

MATCH (2020)

Discovering a novel allergen immunotherapy in house dust mite allergy tolerance research

Read More  

GelGeneCircuit (2020)

Cancer heterogeneity and therapy profiling using bioresponsive nanohydrogels for the delivery of multicolor logic genetic circuits.

Read More  

evolSingleCellGRN (2019)

Constraint, Adaptation, and Heterogeneity: Genomic and single-cell approaches to understanding the evolution of developmental gene regulatory networks

Read More